In the Media
June 11, 2026

Yale Receives $2.5M Gift to Advance Autoimmune Research

Stewart and Judith Colton
Anthony DeCarlo / Yale School of Medicine

Yale School of Medicine has received a $2.5 million gift from the Colton Foundation to advance the Colton Center for Autoimmunity at Yale and strengthen the Colton Consortium for Autoimmunity, the four-institution partnership spanning Yale, Penn, NYU, and Tel Aviv University.

The gift will support a Director’s Fund for early-stage research, recruitment of faculty in human autoimmunity and translational immunology, and multi-institution collaborative projects across the consortium — including a new extramural RFA and a monogenic autoimmune disease initiative led by Carrie Lucas, PhD.

“Collaboration becomes real not when people merely share ideas, but when institutions jointly invest in them,” says Center Director Joseph Craft, MD.

In the MediaCollaboration & InnovationCross-institutional CollaborationRare Autoimmune DiseasesCross-ConsortiumYale University

Featured Experts

Joseph Craft, MD

Joseph Craft, MD

Director, Colton Center for Autoimmunity (Yale University)

Departments of Internal Medicine (Rheumatology, Allergy & Immunology) & Immunobiology, Yale School of Medicine, Yale University
Carrie Lucas, PhD

Carrie Lucas, PhD

Associate Director, Colton Center for Autoimmunity (Yale University)

Department of Immunobiology, Yale School of Medicine, Yale University

Featured Publications

Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group

Rheumatology
Rhee, RL; Bathla, G; Rebello, R; Kurtz, RM; Junek, M; Warrington, KJ; Khalidi, N; Merkel, PA; Guggenberger, KV; Tamhankar, MA; Bley, TA; Vasculitis Clinical Research Consortium May 2025
Biomarker DiscoveryCollaboration & InnovationCross-institutional CollaborationDisease SubtypingEarly Disease DetectionExperimental Platforms & ModelsHuman CohortsReal-world EvidenceRegulatory ScienceTranslational & ClinicalSystemic DiseasesVasculitisUniversity of Pennsylvania

Skin manifestations of VEXAS syndrome and associated genotypes

JAMA Dermatology
Tan, IJ; Ferrada, MA; Ahmad, S; Fike, A; Quinn, KA; Groarke, EM; Beck, DB; Allbritton, J; Castelo-Soccio, L; Young, NS; Patel, BA; Grayson, PC; Cowen, EW June 2024
Biological & MechanisticBiomarker DiscoveryDisease SubtypingExperimental Platforms & ModelsHuman CohortsHuman GeneticsInnate ImmunityTranslational & ClinicalAutoinflammatory DiseasesCross-Cutting & Special PopulationsDermatologic DiseasesRare Autoimmune DiseasesNew York University
From the Consortium

Related News

$5M Gift Establishes Colton Center for Autoimmunity at Mount Sinai to Advance Precision Medicine for Autoimmune Diseases
Announcements Industry & Partnerships
July 21, 2026

$5M Gift Establishes Colton Center for Autoimmunity at Mount Sinai to Advance Precision Medicine for Autoimmune Diseases

A $5 million gift from Judith and Stewart Colton establishes a Colton Center for Autoimmunity at Mount Sinai, expanding the Colton Consortium and advancing precision, early-detection approaches to autoimmune disease research.

Colton Consortium for Autoimmunity Announces $15 Million Investment
Announcements
June 10, 2026

Colton Consortium for Autoimmunity Announces $15 Million Investment

The Colton Foundation has committed $15 million over three years to the Colton Consortium for Autoimmunity — strengthening leadership, expanding faculty, and accelerating collaborative research across four partner institutions.

A New Research Hub for Autoimmunity and Immune Health at Penn Medicine
Announcements
September 5, 2025

A New Research Hub for Autoimmunity and Immune Health at Penn Medicine

Penn Medicine has opened a new research facility housing the Colton Center for Autoimmunity alongside immune health, vaccinology, and infectious disease teams — designed to accelerate breakthrough science through collaboration.